Floatz logo

Therapeutic Asset Ratings

176 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Autologous Bcma/Gprc5D Dual-Target Car-T
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Beijing BiotechP1/2CC (43)
Autologous Cd19/Cd20 Dual-Target Car-T Module
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Beijing BiotechP1/2CC (43)
Autologous Cd19/Cd22 Dual-Target Car-T Module
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Beijing BiotechP1/2CC (43)
Autologous Cd33/Cd123 Dual-Target Car-T Module
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Beijing BiotechP1/2CC (43)
Autologous Cd33/Cll1 Dual-Target Car-T Module
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Beijing BiotechP1/2CC (43)
Autologous Cd5/Cd7 Dual-Target Car-T Module
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Beijing BiotechP1/2CC (43)
Dual-Target Car-Nk Cell Product
Ovarian Carcinoma
Beijing BiotechP1/2CC (43)
Eb-Dnk101 Dual-Targeting Car-Nk Cells
Pancreatic Ductal Adenocarcinoma
Beijing BiotechP1/2CC (43)
Eb-Dnk102 Dual-Targeting Car-Nk Cells
Pancreatic Ductal Adenocarcinoma
Beijing BiotechP1/2CC (43)
Eb-Dualnk
Ovarian Carcinoma
Beijing BiotechP1/2CC (43)
Eb-Nk-301
Metastatic Malignant Neoplasm
Beijing BiotechP1/2CC (43)
Eb-Pt-Car-Nk-S
Advanced or Metastatic Solid Tumors
Beijing BiotechP1/2CC (43)
Fludarabine
Advanced or Metastatic Solid Tumors
Beijing BiotechP1/2CC (43)
Rimiducid
Thymic Carcinoma
Beijing BiotechP1/2CC (43)
Fludarabine
Metastatic Prostate Carcinoma
Beijing BiotechP1CC (42)
Dual-Target Car-Nk Cells
Malignant Glioma
Beijing BiotechP1CC (41)
Dual-Target Car-Nk Cells
HER2 Positive Breast Carcinoma
Beijing BiotechP1/2CC (41)
Eb-Duo-Car-Nk-Cea/Gcc
Metastatic Malignant Neoplasm In The Colon
Beijing BiotechP1/2CC (41)
Autologous Bcma/Cd38 Dual-Target Car-T Module
Multiple Myeloma
Beijing BiotechP1/2CC (40)
Dual-Target Car-Nk Cells
Non-Small Cell Lung Carcinoma
Beijing BiotechP1/2CC (40)
Eb-Duo-Car-Nk-Cea/Gcc
Colorectal Cancer
Beijing BiotechP1/2CC (40)
Eb-Nk-301
Cancer
Beijing BiotechP1/2CC (40)
Eb-Dt-Nk-Uc101
Urinary Bladder Carcinoma
Beijing BiotechP1C (39)
Eb-Dt-Nk-Uc101
Urothelial Carcinoma
Beijing BiotechP1C (39)
Dual-Target Car-Nk Cells
Glioblastoma
Beijing BiotechP1C (37)
Showing 151 to 175 of 176 assets
PreviousPage 7 of 8Next